Base Year
Historical Year
Forecast Year
The global obsessive-compulsive disorder drugs market is projected to grow at a CAGR of almost 4.8% over the forecast period of 2024-2032.
The global obsessive-compulsive disorder drugs market is being driven by the rising investment in R&D and health care sector, the rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Obsessive-compulsive disorder (OCD) is a medical condition characterised by unreasonable thoughts and obsessions or fears, which leads to compulsive behaviour in an individual. Antidepressants are often the first medications prescribed to treat OCD.
The global obsessive-compulsive disorder drugs market can be divided on the basis of segments like products and regions.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The EMR report looks into the regional obsessive-compulsive disorder drugs markets like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The development of new drugs to treat the obsessive-compulsive disorder is one of the major factors driving the growth of the industry globally. With rising consumer awareness, the demand for drugs with enhanced bioavailability, safety, and dosage parameters has increased, leading manufacturers to focus on the R&D of new OCD drugs. Thus, the launch of these products is expected to aid the growth of the obsessive-compulsive disorder drugs industry over the forecast period. Further, the growing acceptance of off-label drugs in combination with the approved therapies is providing a boost to the industry.
The SSRI segment, among other product types, dominated the industry in 2020, owing to the presence of several SSRIs including fluoxetine, fluvoxamine, paroxetine, and others, coupled with their fewer side effects in comparison to other drug types. Further, North America accounted for the largest share in the industry in 2020 due to the rising prevalence of obsessive-compulsive disorder and increased government initiatives in the region to combat this condition. The region is expected to dominate the obsessive-compulsive disorder drugs market in the forecast period as well.
The report presents a detailed analysis of the following key players in the global obsessive-compulsive disorder drugs industry, looking into their capacity, market shares, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
The EMR report gives an in-depth insight into the market by providing a SWOT analysis as well as an analysis of Porter’s Five Forces model.
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Product |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
Obsessive-Compulsive Disorder Drugs Market Size
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The global obsessive-compulsive disorder drugs market is further likely to grow at a CAGR of 4.8% in the forecast period of 2024 and 2032.
The major drivers of the industry include the rising investment in the R&D and health care industry, development of new drugs to treat the obsessive-compulsive disorder, rising consumer awareness, and increased government initiatives.
The rapid development in the OCD treatment procedures, and the growing demand for off-level drugs and therapies are the key factors driving industry growth globally.
The major regions in the industry are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.
The major products in the industry are SSRI and TCA, among others.
The key players in the industry are Eli Lilly and Company, GlaxoSmithKline Plc, Lupin, H. Lundbeck A/S, and Pfizer Inc., among others.
Purchase Full Report
Datasheet
Single User License
One User
Five User License
Five Users
Corporate License
Unlimited Users
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
Share